Deregulated activation of matriptase in breast cancer cells
- 1 January 2002
- journal article
- research article
- Published by Springer Nature in Clinical & Experimental Metastasis
- Vol. 19 (7), 639-649
- https://doi.org/10.1023/a:1020985632550
Abstract
Matriptase is an epithelial-derived, cell surface serine protease. This protease activates hepatocyte growth factor (HGF) and urokinase plasminogen activator (uPA), two proteins thought to be...Keywords
This publication has 44 references indexed in Scilit:
- Type II Transmembrane Serine ProteasesJournal of Biological Chemistry, 2001
- High levels of TIMP-2 correlate with adverse prognosis in breast cancerInternational Journal of Cancer, 2000
- Sphingosine-1-phosphate inhibits motility of human breast cancer cells independently of cell surface receptors.1999
- Rho GTPases are over-expressed in human tumorsInternational Journal of Cancer, 1999
- Expression of plasminogen activator inhibitor type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis, and metastasis to lung and liver in an athymic mouse model.Journal of Clinical Investigation, 1995
- Identification and characterization of a novel matrix-degrading protease from hormone-dependent human breast cancer cells.1993
- Expression of the metalloproteinase matrilysin in DU-145 cells increases their invasive potential in severe combined immunodeficient mice.1993
- Suppression of Invasion by Inducible Expression of Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) in B 16-F10 Melanoma CellsJNCI Journal of the National Cancer Institute, 1992
- Isolation and characterization of alpha 2-macroglobulin-protease complexes from purified mouse mammary tumor virus and culture supernatants from virus-infected cell lines.Journal of Biological Chemistry, 1992
- LOSS OF BASEMENT-MEMBRANE COMPONENTS BY INVASIVE TUMORS BUT NOT BY THEIR BENIGN COUNTERPARTS1983